N Engl J Med. 2018 Apr 26;378(17):1604-1610. doi: 10.1056/NEJMoa1714322.
Prenatal Correction of X-Linked Hypohidrotic Ectodermal Dysplasia.
Schneider H1, Faschingbauer F1, Schuepbach-Mallepell S1, Körber I1, Wohlfart S1, Dick A1, Wahlbuhl M1, Kowalczyk-Quintas C1, Vigolo M1, Kirby N1, Tannert C1, Rompel O1, Rascher W1, Beckmann MW1, Schneider P1.
Genetic deficiency of ectodysplasin A (EDA) causes X-linked hypohidrotic ectodermal dysplasia (XLHED), in which the development of sweat glands is irreversibly impaired, an condition that can lead to life-threatening hyperthermia. We observed normal development of mouse fetuses with Eda mutations after they had been exposed in utero to a recombinant protein that includes the receptor-binding domain of EDA. We administered this protein intraamniotically to two affected human twins at gestational weeks 26 and 31 and to a single affected human fetus at gestational week 26; the infants, born in week 33 (twins) and week 39 (singleton), were able to sweat normally, and XLHED-related illness had not developed by 14 to 22 months of age. (Funded by Edimer Pharmaceuticals and others.).
- In Utero Protein Therapy for an Inherited Developmental Disorder. [N Engl J Med. 2018]
- Prostate Cancer Metastasis - Fueled by Fat? [N Engl J Med. 2018]